Fanolesomab - CISMeF

Preferred Label : Fanolesomab;

NCIt synonyms : Immunoglobulin M (Mouse Monoclonal Rb5 Mu-Chain Anti-Human Antigen CD 15), Disulfide with Mouse Monoclonal Rb5 Light Chain, Pentamer; Immunoglobulin M, Anti-(Human CD15 (Antigen)) (Mouse Monoclonal Rb5 Mu-Chain), Disulfide with Mouse Monoclonal Rb5 Light Chain, Pentamer;

NCIt definition : A mouse monoclonal antibody directed against human cluster of differentiation 15 (CD15 or 3-fucosyl-N-acetyllactosamine). Fanolesomab binds to CD15; radioactive labeled fanolesomab may facilitate the visualization of infection sites upon imaging. The CD15 antigen, a carbohydrate adhesion molecule, is expressed on the surface of the majority of granulocytes, including neutrophils and eosinophils and, to a lesser extent, on monocytes. Due to life-threatening side effects, this antibody is no longer on the market.;

UNII : 67ETM2384N;

CAS number : 848033-49-8;

Details

Origin ID

C95322;

UMLS CUI

C1572727;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- techneticum TC-99M fanolesomab [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- techneticum TC-99M fanolesomab [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients